Ernie Stern interviewed by San Fernando Valley Business Journal on biotech research in M&A

Our Washington, D.C. partner Ernie Stern was recently interviewed by San Fernando Valley Business Journal for an article titled “Biotech: Partnership Leads to Strategic Purchase.”

Ernie points to a deal being based on the specifics of the life science industry. Here are a few excerpts from the article:

Prior to HemaCare, Charles River acquired six companies since 2016, including CiToxLAB for $510 million, MPI Research for $800 million and KWS BioTest for an undisclosed amount, according to CrunchBase. 

For Ernie Stern, an attorney and partner at the firm Culhane Meadows in Dallas who specializes in mergers and acquisitions, this deal is based on the specifics of the life science industry.

“That’s not uncommon. You’ve reached some sort of collaboration agreement and might support certain tests and trials,” said Stern. “That gives them the opportunity to say they like what they see, and the progress has been made and they understand the progress better, and the people better, so that they can assess the risk better. … It gives them the opportunity to either make an acquisition or exclusive license, something that gives them the benefit of the risk they have undertaken.”

In Charles River’s case, the partnership helped the company see how HemaCare could fill gaps in its ability to support clients. This is especially true in the cell therapy space, Dunn told the Business Journal. 

The complete article can be found HERE.

*Culhane Meadows is ranked by U.S. News/Best Law Firms in Technology Law, Bankruptcy/Reorganization Law, and Information Technology Law. This website and the communications herein may be considered attorney advertising. Previous results are not a guarantee of future outcome. This website is for informational purposes only and does not constitute legal advice. The information herein is not intended to create an attorney-client or similar relationship. Until you establish such a relationship and receive an engagement letter, you have not hired a Culhane Meadows attorney nor become a client of the firm. Whether you are a new or existing client of the firm, Culhane Meadows must determine that there is no conflict of interest and that it is willing and otherwise able to accept the new engagement before representing you on a new matter. Only if and after Culhane Meadows has informed you it is willing and able to accept your new matter should you send the firm any information or documents that you consider private or confidential. Such information will not be treated as private, confidential or otherwise protected from disclosure until Culhane Meadows has communicated in writing that it is willing and able to accept your new matter and provide you with legal counsel. Whether you need legal services and which lawyer or law firm you select are important decisions that should not be based on this website alone.